Kudo Biotechnology, an end-to-end mRNA contract development and manufacturing organization (CDMO), has been selected to present both a scientific poster as well as a flash talk at the 3rd Annual mRNA-Based Therapeutics Summit, held from July 28-30 in Boston, at the Boston Convention and Exhibition Center.

This mRNA-dedicated conference will be attended by all major mRNA players, featuring more than 400 key mRNA opinion leaders and more than 100 world-class speakers, across large pharma, innovative biotechs, and academia. Organized by Hanson Wade, the Summit covers a comprehensive range of topics from next-generation mRNA-mediated technologies, the broad trend of the emergence of mRNA-based therapeutics and vaccines, future collaborations in the complex mRNA landscape, the regulatory environment for first-in-class therapeutics and best-in-class vaccines, as well as approaches to harness novel innovations & platforms to progress next-generation mRNA-based medicines.

Kudo Biotechnology is proud to have been selected to present its innovative work for this prestigious conference in both a poster and flash talk format. We are presenting a short talk on the Conference Day Two (Friday, July 28th) at 10:15am. We cordially welcome you to participate and engage with us during and after the session.

Join us at this flagship event in the fast-growing mRNA field, and find out more about our solutions and how we fully address the needs of our customers along the mRNA GMP manufacturing value chain, from sequence through to finish-filled drug product, as well as analytical and process development.

To learn more, contact us at info@kudobio.com

We hope to see you there at the 3rd Annual mRNA-Based Therapeutics Summit in Boston next week! We will also be attending Bioprocess International in Boston from Sep 18-21, 2023, as well as the 30th Annual Congress of the European Society of Gene and Cell Therapy in Brussels from Oct 24-27, 2023.